AU3009801A - Combinations of medicaments for treating viral diseases - Google Patents

Combinations of medicaments for treating viral diseases

Info

Publication number: AU3009801A
Authority: AU; Australia
Prior art keywords: medicaments; combinations; viral diseases; treating viral; treating
Prior art date: 1999-12-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU30098/01A

Inventor

Karl Deres

Siegfried Goldmann

Erwin Graef

Thomas Kramer

Ulrich Niewohner

Arnold Paessens

Karl-Heinz Schlemmer

Jurgen Stoltefuss

Olaf Weber

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer AG

Original Assignee

Bayer AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-22

Filing date

2000-12-12

Publication date

2001-07-03

1999-12-22 Priority claimed from DE1999162010 external-priority patent/DE19962010A1/en

2000-03-14 Priority claimed from DE2000112259 external-priority patent/DE10012259A1/en

2000-12-12 Application filed by Bayer AG filed Critical Bayer AG

2001-07-03 Publication of AU3009801A publication Critical patent/AU3009801A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU30098/01A 1999-12-22 2000-12-12 Combinations of medicaments for treating viral diseases Abandoned AU3009801A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE19962010		1999-12-22
DE1999162010 DE19962010A1 (en)	1999-12-22	1999-12-22	Antiviral combination based on dihydropyrimidine derivatives and non-dihydropyrimidine HBV antiviral agents, are useful for treatment of HBV infections
DE10012259		2000-03-14
DE2000112259 DE10012259A1 (en)	2000-03-14	2000-03-14	Antiviral combination based on dihydropyrimidine derivatives and non-dihydropyrimidine HBV antiviral agents, are useful for treatment of HBV infections
PCT/EP2000/012570 WO2001045712A1 (en)	1999-12-22	2000-12-12	Combinations of medicaments for treating viral diseases

Publications (1)

Publication Number	Publication Date
AU3009801A true AU3009801A (en)	2001-07-03

Family

ID=26004825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU30098/01A Abandoned AU3009801A (en)	1999-12-22	2000-12-12	Combinations of medicaments for treating viral diseases

Country Status (2)

Country	Link
AU (1)	AU3009801A (en)
WO (1)	WO2001045712A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102066369B (en)	2007-06-18	2013-05-29	广东东阳光药业有限公司	Bromo-phenyl substituted thiazolyl dihydropyrimidines
CN104302626B (en) *	2012-01-06	2016-09-07	爱尔兰詹森科学公司	4,4-disubstituted-1,4-dihydropyrimidines and their use as medicaments for the treatment of hepatitis B
US20130267517A1 (en)	2012-03-31	2013-10-10	Hoffmann-La Roche Inc.	Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
AU2013311705A1 (en)	2012-09-10	2015-02-05	F. Hoffmann-La Roche Ag	6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection
KR20160128305A (en)	2014-02-05	2016-11-07	노비라 테라퓨틱스, 인코포레이티드	Combination therapy for treatment of hbv infections
NZ727601A (en)	2014-05-30	2022-01-28	Qilu Pharmaceutical Co Ltd	Dihydropyrimido fused ring derivative as hbv inhibitor
CN105153164B (en) *	2014-05-30	2018-10-30	齐鲁制药有限公司	Dihydro-pyrimidin and ring derivatives as HBV inhibitor
HK1255463A1 (en) *	2015-11-03	2019-08-16	F. Hoffmann-La Roche Ag	Combination therapy of an hbv capsid assembly inhibitor and an interferon
WO2017108630A1 (en) *	2015-12-21	2017-06-29	F. Hoffmann-La Roche Ag	Combination therapy of an hbsag inhibitor and an hbv capsid assembly inhibitor
KR20250089561A (en) *	2016-01-08	2025-06-18	아뷰터스 바이오파마 코포레이션	Therapeutic compositions and methods for treating hepatitis b
EP3645516A4 (en)	2017-06-27	2021-07-07	Janssen Pharmaceutica NV	Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infections
AR115131A1 (en)	2017-11-02	2020-12-02	Aicuris Gmbh & Co Kg	HIGHLY ACTIVE INDOLO-2-CARBOXAMIDES REPLACED WITH PYRAZOLO-PYRIMIDINE ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)
KR20200083551A (en)	2017-11-02	2020-07-08	아이쿠리스 게엠베하 운트 코. 카게	New highly active amino-thiazole substituted indole-2-carboxamide active against hepatitis B virus (HBV)
WO2019214610A1 (en) *	2018-05-08	2019-11-14	Janssen Sciences Ireland Unlimited Company	Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseases
US11053235B2 (en)	2018-08-09	2021-07-06	Janssen Sciences Ireland Unlimited Company	Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseases
AR116947A1 (en)	2018-11-02	2021-06-30	Aicuris Gmbh & Co Kg	DERIVATIVES OF UREA 6,7-DIHIDRO-4H-PIRAZOLO [1,5-A] PIRAZINAS-INDOL-2-CARBOXAMIDAS ACTIVE AGAINST THE VIRUS OF HEPATITIS B (HBV)
UY38439A (en)	2018-11-02	2020-05-29	Aicuris Gmbh & Co Kg	NOVELTY UREA 6,7-DIHYDRO-4H-PYRAZOLE [4,3-C] PYRIDINES ACTIVE AGAINST THE VIRUS OF HEPATITIS B (HBV)
EP3873913A1 (en)	2018-11-02	2021-09-08	AiCuris GmbH & Co. KG	Novel urea 6,7-dihydro-4h-thiazolo[5,4-c]pyridines active against the hepatitis b virus (hbv)
AR117188A1 (en)	2018-11-02	2021-07-21	Aicuris Gmbh & Co Kg	DERIVATIVES OF UREA 6,7-DIHIDRO-4H-PIRAZOLO [1,5-A] PYRAZINES ACTIVE AGAINST THE VIRUS OF HEPATITIS B (HBV)
UY38434A (en)	2018-11-02	2020-05-29	Aicuris Gmbh & Co Kg	NEW 6,7-DIHYDRO-4H-PYRAZOLE [1,5-A] PIRAZIN INDOL-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)
UY38435A (en)	2018-11-02	2020-05-29	Aicuris Gmbh & Co Kg	NEW UREA 6,7-DIHIDRO-4H-PIRAZOL [1,5-A] PIRAZINAS ACTIVE AGAINST THE VIRUS OF HEPATITIS B (HBV)
KR20220003023A (en)	2019-04-30	2022-01-07	아이쿠리스 게엠베하 운트 코. 카게	Novel oxalyl piperazine active against hepatitis B virus (HBV)
BR112021021564A2 (en)	2019-04-30	2022-01-04	Aicuris Gmbh & Co Kg	Innovative indole-2-carboxamides active against hepatitis b virus (hbv)
PH12021552733A1 (en)	2019-04-30	2023-01-16	Aicuris Gmbh & Co Kg	Novel indolizine-2-carboxamides active against the hepatitis b virus (hbv)
CN113767102A (en)	2019-04-30	2021-12-07	艾库里斯有限及两合公司	Novel phenyl and pyridylureas having activity against Hepatitis B Virus (HBV)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5059418A (en) *	1989-09-20	1991-10-22	The Administrators Of The Tulane Educational Fund	Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines
AU5923998A (en) *	1997-01-31	1998-08-25	Avid Therapeutics Inc.	2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
DE19817262A1 (en) *	1998-04-18	1999-10-21	Bayer Ag	New dihydropyrimidine derivatives and their corresponding mesomers useful in treatment of hepatitis
DE19817265A1 (en) *	1998-04-18	1999-10-21	Bayer Ag	Treating hepatitis B using new or known dihydropyrimidine derivative antiviral agents
DE19817264A1 (en) *	1998-04-18	1999-10-21	Bayer Ag	New dihydropyrimidine derivatives and their corresponding mesomers useful as antiviral agents

2000
- 2000-12-12 WO PCT/EP2000/012570 patent/WO2001045712A1/en not_active Ceased
- 2000-12-12 AU AU30098/01A patent/AU3009801A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2001045712A8 (en)	2001-09-13
WO2001045712A1 (en)	2001-06-28

Publication	Publication Date	Title
AU3009801A (en)	2001-07-03	Combinations of medicaments for treating viral diseases
AU2001244188A1 (en)	2001-09-24	Medicaments against viral diseases
AU2001276860A1 (en)	2002-01-30	Medicaments for chemotherapeutic treatment of disease
IL154875A0 (en)	2003-10-31	Pyrazole derivatives for the treatment of viral diseases
AU3891299A (en)	1999-12-06	Combination therapy for treatment of depression
AU7622000A (en)	2001-05-10	Compounds for the treatment of viral-mediated diseases
AU2000265525A1 (en)	2002-03-13	Medicament for treating intestinal diseases
AU7731700A (en)	2001-04-30	Low dose ifn-gamma for treatment of disease
AU2281601A (en)	2001-07-03	Treatment of viral infections using levovirinTM
AUPQ232599A0 (en)	1999-09-09	Drug for treating fractures
AU2002322082A1 (en)	2003-01-02	Pharmaceutical composition for the treatment of viral infection
AU3684395A (en)	1996-05-02	Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
AU3004000A (en)	2000-09-14	Methods for the treatment of apolipoprotein e related diseases
AU4215499A (en)	2002-07-08	Treatment of neurodegenerative diseases
AU7449698A (en)	1998-12-11	Therapeutic agents for respiratory diseases
AU4145999A (en)	1999-12-13	Topical drug for the treatment of viral infections
AU3760900A (en)	2000-10-09	Treatment of menstrual function
AU1405001A (en)	2001-05-30	Treatment of diseases
AUPQ367699A0 (en)	1999-11-18	Treatment of cancer
AU5552400A (en)	2001-01-09	Treatment of cancer
AU5611701A (en)	2001-10-03	Agent for the diagnosis and therapy of viral diseases
IL151188A0 (en)	2003-04-10	Medicament for viral diseases
GB0028484D0 (en)	2001-01-10	Imidazolone derivatives for the treatment of viral diseases
AU3501100A (en)	2000-09-14	Synergistic combination for treatment of viral-mediated diseases
AU1618901A (en)	2001-05-30	Treatment of rosacea

Legal Events

Date	Code	Title	Description
2002-08-29	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase